Autres langues Innovation1 Biotech Inc.

Actions

IVBT

US39809D2018

Temps Différé OTC Markets Autres places de cotation 15:31:07 19/04/2024			Varia. 5j.	Varia. 1 janv.
0,0008 ^USD	-96,36%		-.--%	-99,07%

17/01	Innovation1 Biotech Inc. publie ses résultats pour l'exercice clos le 31 août 2023	CI
2023	Innovation1 Biotech Inc. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 31 mai 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	17/01
Innovation1 Biotech Inc. announced that it has received $0.15 million in funding	06/12
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	01/11
Innovation1 Biotech : New Financial Obligation - Form 8-K	16/10/23
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	11/10/23
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	13/09/23
Innovation1 Biotech Inc. announced that it has received $0.066891 million in funding	01/09/23
Innovation1 Biotech Inc. Announces Resignation of Patrick Morris as Chairman of the Board	11/08/23
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	30/05/23
Innovation1 Biotech Inc. Announces Resignation of Jeffrey Kraws as a Director	24/04/23
Innovation1 Biotech : Material Agreement - Form 8-K	24/04/23
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	24/04/23
Innovation1 Biotech Inc. announced that it expects to receive $0.28 million in funding from Cavalry Fund I Management, LLC, Lincoln Park Capital, LLC, L1 Capital Pty. Limited	13/04/23
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	17/01/23
Innovation1 Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	17/01/23
Innovation1 Biotech Inc. announced that it has received $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC	27/12/22
Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	15/12/22
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/12/22
Innovation1 Biotech Inc. Auditor Raises 'Going Concern' Doubt	15/12/22
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	12/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Innovation1 Biotech Inc.

Actions

IVBT

US39809D2018

Autres langues

Filtres